SNDX Company Profile and Key Details

Q: Who are the executives of SNDX?

Sharon KlahreVice President of Investor Relations & CommunicationsDr. Peter Ordentlich B.Sc., Ph.D.Co-Founder & Chief Scientific OfficerDr. Briggs W. Morrison M.D.Pres, Head of R&D and DirectorDr. Ronald M. Evans Ph.D.Co-Founder, Advisor and Chair of Scientific Advisory BoardDr. Michael Downes Ph.D.Co-FounderDr. Briggs W. Morrison M.D., Ph.D.Pres, Head of R&D and DirectorMr. Michael A. Metzger M.B.A.Chief Executive Officer & DirectorDr. Anjali Ganguli Ph.D.Chief Bus. OfficerMr. Keith Alan Goldan CPAChief Financial Officer, Treasurer & Chief Accounting OfficerMr. Steve M. SabusChief Commercial OfficerMr. Luke J. AlbrechtSenior Vice President, Gen. Counsel & Sec.Dr. Catherine Madigan M.D.Chief Medical OfficerMr. Alexander NolteInterim Chief Financial Officer, Principal Accounting Officer & Treasurer

NASDAQ : SNDX

Syndax Pharmaceuticals

$18.20

0.23+1.28%

At Close 4:00 PM

55.95

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Syndax Pharmaceuticals, Inc. (SNDX) stock surged +1.28%, trading at $18.20 on NASDAQ, up from the previous close of $17.97. The stock opened at $18.03, fluctuating between $17.77 and $18.34 in the recent session.

Stock Snapshot

17.97

Prev. Close

1.61B

Market Cap

17.765

Day Low

-7.25

P/E Ratio

-2.51

EPS (TTM)

-2.21

Cash Flow per Share

18.03

Open

88.61M

Number of Shares

18.34

Day High

94.89%

Free Float in %

7.64

Book Value

1.34M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 25, 2026	18.03	18.35	17.77	18.20	1.32M
Sep 24, 2026	17.52	18.11	17.18	17.97	2.07M
Sep 23, 2026	18.20	18.47	17.09	17.64	2.09M
Sep 21, 2026	17.74	18.45	17.39	18.07	2.11M
Sep 18, 2026	17.65	17.95	17.37	17.62	5.18M
Sep 17, 2026	17.53	18.05	17.37	17.68	2.58M
Sep 16, 2026	18.08	18.11	17.25	17.28	2.33M
Sep 15, 2026	18.19	18.19	17.71	18.09	1.13M
Sep 14, 2026	18.30	18.68	18.24	18.35	1.14M
Sep 11, 2026	19.01	19.02	18.02	18.18	1.22M
Sep 10, 2026	19.67	19.69	18.40	18.82	1.65M
Sep 09, 2026	19.82	20.20	19.69	19.84	1.24M
Sep 08, 2026	20.19	20.48	19.90	19.94	1.2M
Sep 04, 2026	20.46	21.00	20.46	20.56	1.36M
Sep 03, 2026	20.85	20.99	20.54	20.68	1.92M
Sep 02, 2026	20.23	21.00	19.97	20.78	2.02M
Sep 01, 2026	19.29	20.15	19.09	20.10	1.41M
Aug 31, 2026	19.44	19.46	19.00	19.29	1.4M
Aug 28, 2026	19.98	20.05	19.47	19.54	1.04M
Aug 27, 2026	20.01	20.23	19.70	20.16	652.35K

Contact Details

New York City, NY 10017

United States

https://www.syndax.com 781 419 1400

About Company

Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML). Another significant candidate is SNDX-6352, or axatilimab, a monoclonal antibody designed to block the colony stimulating factor 1 (CSF-1) receptor, intended for patients suffering from chronic graft versus host disease (cGVHD). The company is additionally progressing Entinostat. Syndax has also established strategic collaborations, including a research and development agreement with the National Cancer Institute, a clinical trial agreement with the Eastern Cooperative Oncology Group, and a license agreement with Kyowa Hakko Kirin Co., Ltd. Founded in 2005, Syndax Pharmaceuticals, Inc. maintains its corporate headquarters in Waltham, Massachusetts.

Stock Peers

ARGX

-2.73-0.28%

argenx SE$959.49 REGN

-7.98-1.00%

Regeneron Pharmaceuticals, Inc.$788.04 VRTX

3.81+0.73%

Vertex Pharmaceuticals Incorporated$526.19 MDGL

3.35+0.65%

Madrigal Pharmaceuticals, Inc.$516.56 UTHR

3.24+0.69%

United Therapeutics Corporation$475.45 ONC

0.88+0.24%

BeOne Medicines AG$360.85 KRYS

0.86+0.25%

Krystal Biotech, Inc.$345.82 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

2.48+0.83%

Ligand Pharmaceuticals Incorporated$301.52 PRAX

-1.01-0.36%

Praxis Precision Medicines, Inc.$280.78

Frequently Asked Questions

What is the current Syndax Pharmaceuticals, Inc. (SNDX) stock price?

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stock price is $18.20 in the last trading session. During the trading session, SNDX stock reached the peak price of $18.34 while $17.77 was the lowest point it dropped to. The percentage change in SNDX stock occurred in the recent session was 1.28% while the dollar amount for the price change in SNDX stock was $0.23.

SNDX's industry and sector of operation?

The NASDAQ listed SNDX is part of Biotechnology industry that operates in the broader Healthcare sector. Syndax Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SNDX?

Sharon Klahre
Vice President of Investor Relations & Communications
Dr. Peter Ordentlich B.Sc., Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Briggs W. Morrison M.D.
Pres, Head of R&D and Director
Dr. Ronald M. Evans Ph.D.
Co-Founder, Advisor and Chair of Scientific Advisory Board
Dr. Michael Downes Ph.D.
Co-Founder
Dr. Briggs W. Morrison M.D., Ph.D.
Pres, Head of R&D and Director
Mr. Michael A. Metzger M.B.A.
Chief Executive Officer & Director
Dr. Anjali Ganguli Ph.D.
Chief Bus. Officer
Mr. Keith Alan Goldan CPA
Chief Financial Officer, Treasurer & Chief Accounting Officer
Mr. Steve M. Sabus
Chief Commercial Officer
Mr. Luke J. Albrecht
Senior Vice President, Gen. Counsel & Sec.
Dr. Catherine Madigan M.D.
Chief Medical Officer
Mr. Alexander Nolte
Interim Chief Financial Officer, Principal Accounting Officer & Treasurer

How SNDX did perform over past 52-week?

SNDX's closing price is 40.11% higher than its 52-week low of $12.99 where as its distance from 52-week high of $25.59 is -28.88%.

How many employees does SNDX have?

Number of SNDX employees currently stands at 298.

Link for SNDX official website?

Official Website of SNDX is: https://www.syndax.com

How do I contact SNDX?

SNDX could be contacted at phone 781 419 1400 and can also be accessed through its website. SNDX operates from 730 Third Avenue, New York City, NY 10017, United States.

How many shares of SNDX are traded daily?

SNDX stock volume for the day was 1.34M shares. The average number of SNDX shares traded daily for last 3 months was 1.66M.

What is the market cap of SNDX currently?

The market value of SNDX currently stands at $1.61B with its latest stock price at $18.20 and 88.61M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	298
Beta	0.37
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	298
Beta	0.37
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SNDX Company Profile and Key Details

Syndax Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways